Drug Use-results Surveillance of SOVRIAD capsules100mg.

Not Applicable

Recruiting

• Conditions: chronic hepatitis C.

• Registration Number: JPRN-UMIN000015896
• Lead Sponsor: Janssen Phrmaceutical K.K.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-12-15
• Study Completion: 2017-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 2200

Inclusion Criteria

Not provided

Exclusion Criteria

NA

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Safety(Adverse Drug Reaction) Effectiveness(SVR12,SVR24)